NDASUBCUTANEOUSPOWDERPriority Review
Approved
Feb 2026
Lifecycle
Launch
Competitive Pressure
30/100
Clinical Trials
2
Clinical Trials (2)
A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.
Started Dec 2024
24 enrolled
Achondroplasia
A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia
Started Jul 2024
22 enrolled
Achondroplasia
External Resources